JPRN-UMIN000005516招募中未知
Single-Agent Molecularly Targeted Therapy for Adults with Recurrent Glioblastoma Multiforme: A Meta-Analysis - Molecularly targeted monotherapy in recurrent GBM
Kurume University School of Medicine0 个研究点目标入组 1,000 人开始时间: 2011年4月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •After a review of abstracts, articles were excluded if they did not contain the relevant outcome data or if they selected patients retrospectively based on known outcomes. In the case of different publications describing the same patient cohort, only the most recent publication was used for further analysis.
研究者
相似试验
招募中
不适用
Combination of molecularly-targeted therapy with stereotactic body radiotherapy in hepatocellular carcinoma with major vascular invasioHepatocellular carcinoma with major vascular invasionJPRN-UMIN000030718Osaka International Cancer Institute20
招募中
不适用
The efficacy of molecular targeted therapy for unresectable hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000035136Kyoto University150
已完成
不适用
Combination therapy with a molecular target drug and iron chelator for the treatment of intractable hepatocellular carcinomaadvanced hepatocellular carcinomaJPRN-UMIN000013461Department of Gastroenterology, Okayama University Hospital10
进行中（未招募）
1 期
Obinutuzumab (GA101) in combination with PixantrOne for the treatment of patients with relapsed Aggressive B-cell LymphomaEUCTR2014-004780-21-DEniversity Medical Center of the Johannes Gutenberg70
招募中
不适用
Evaluation of the efficacy of molecular targeted drugs using biopsy samples in patients with advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000039887Department of Gastroenterology and Metabolism, Hiroshima University Hospital50